Please use this identifier to cite or link to this item:
Title: Molecular characterization and antimicrobial susceptibilities of Clostridium difficile clinical isolates from Victoria, Australia.
Austin Authors: Mackin, Kate E;Elliott, Briony;Kotsanas, Despina;Howden, Benjamin P ;Carter, Glen P;Korman, Tony M;Riley, Thomas V;Rood, Julian I;Jenkin, Grant A;Lyras, Dena
Affiliation: Monash Infectious Diseases, Monash Health, Clayton, VIC, Australia
PathWest Laboratory Medicine, Nedlands, WA, Australia
Department of Microbiology, Austin Health, Heidelberg, Victoria, Australia
School of Pathology and Laboratory Medicine, The University of Western Australia, Nedlands, WA, Australia
Department of Microbiology, Monash University, Clayton, VIC, Australia
Department of Microbiology and Immunology, University of Melbourne, VIC, Australia
Department of Microbiology, Monash Health, Clayton, VIC, Australia
Issue Date: 2-May-2015
Publication information: Anaerobe 2015; 34(): 80-3
Abstract: Some Australian strain types of Clostridium difficile appear unique, highlighting the global diversity of this bacterium. We examined recent and historic local isolates, finding predominantly toxinotype 0 strains, but also toxinotypes V and VIII. All isolates tested were susceptible to vancomycin and metronidazole, while moxifloxacin resistance was only detected in recent strains.
Gov't Doc #: 25944720
DOI: 10.1016/j.anaerobe.2015.05.001
Journal: Anaerobe
Type: Journal Article
Subjects: Clostridium difficile
Clostridium difficile Australia
Clostridium difficile antibiotic resistance
Clostridium difficile epidemiology
Clostridium difficile toxinotypes
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Apr 12, 2024

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.